Shamburg News · 8-K filed Nov 18, 2026, 4:58 PM EST
Evofem Biosciences Effects 1-for-1,500 Reverse Stock Split, New CUSIP and Temporary EVFMD Ticker
EVFM · Evofem Biosciences, Inc.
- Stock split
- Reg FD disclosure
- Materiality: high
Evofem Biosciences, Inc. effected a 1-for-1,500 reverse stock split of its common stock, approved by shareholders at the November 26, 2025 Annual Meeting, with the Certificate of Amendment filed November 5, 2026 and a Certificate of Correction filed November 17, 2026 moving the effective time to November 18, 2026. Fractional shares will be settled in cash at the closing price on the trading day before the Effective Time, stated as $0.0043. The common stock will trade as EVFMD for 20 business days under new CUSIP 30048L401 before reverting to EVFM.
Source: SEC EDGAR, Form 8-K, Items 5.03, 7.01, 9.01, accession 0001493152-26-053094.
Written from the filing by Shamburg Markets. Figures are as reported by the company.